prosapient limited
prosapient limited Company Information
Company Number
10704431
Next Accounts
Sep 2025
Shareholders
nominee of smedvig capital xv lp
margaryta polishchuk
View AllGroup Structure
View All
Industry
Market research and public opinion polling
Registered Address
floor 5 33 holborn, london, EC1N 2HT
Website
prosapient.comprosapient limited Estimated Valuation
Pomanda estimates the enterprise value of PROSAPIENT LIMITED at £23.2m based on a Turnover of £28.3m and 0.82x industry multiple (adjusted for size and gross margin).
prosapient limited Estimated Valuation
Pomanda estimates the enterprise value of PROSAPIENT LIMITED at £0 based on an EBITDA of £-2m and a 4.82x industry multiple (adjusted for size and gross margin).
prosapient limited Estimated Valuation
Pomanda estimates the enterprise value of PROSAPIENT LIMITED at £10.4m based on Net Assets of £6.4m and 1.64x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Prosapient Limited Overview
Prosapient Limited is a live company located in london, EC1N 2HT with a Companies House number of 10704431. It operates in the market research and public opinion polling sector, SIC Code 73200. Founded in April 2017, it's largest shareholder is nominee of smedvig capital xv lp with a 19.6% stake. Prosapient Limited is a young, large sized company, Pomanda has estimated its turnover at £28.3m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Prosapient Limited Health Check
Pomanda's financial health check has awarded Prosapient Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
3 Weak
Size
annual sales of £28.3m, make it larger than the average company (£9.8m)
£28.3m - Prosapient Limited
£9.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 54%, show it is growing at a faster rate (6.3%)
54% - Prosapient Limited
6.3% - Industry AVG
Production
with a gross margin of 62.7%, this company has a comparable cost of product (60.2%)
62.7% - Prosapient Limited
60.2% - Industry AVG
Profitability
an operating margin of -14.3% make it less profitable than the average company (6%)
-14.3% - Prosapient Limited
6% - Industry AVG
Employees
with 244 employees, this is above the industry average (60)
244 - Prosapient Limited
60 - Industry AVG
Pay Structure
on an average salary of £60.1k, the company has an equivalent pay structure (£65.5k)
£60.1k - Prosapient Limited
£65.5k - Industry AVG
Efficiency
resulting in sales per employee of £115.9k, this is less efficient (£152.2k)
£115.9k - Prosapient Limited
£152.2k - Industry AVG
Debtor Days
it gets paid by customers after 36 days, this is earlier than average (68 days)
36 days - Prosapient Limited
68 days - Industry AVG
Creditor Days
its suppliers are paid after 14 days, this is quicker than average (34 days)
14 days - Prosapient Limited
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Prosapient Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 34 weeks, this is more cash available to meet short term requirements (12 weeks)
34 weeks - Prosapient Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 54.3%, this is a lower level of debt than the average (61.8%)
54.3% - Prosapient Limited
61.8% - Industry AVG
PROSAPIENT LIMITED financials
Prosapient Limited's latest turnover from December 2023 is £28.3 million and the company has net assets of £6.4 million. According to their latest financial statements, Prosapient Limited has 244 employees and maintains cash reserves of £3.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Aug 2019 | Aug 2018 | |
|---|---|---|---|---|---|---|---|
| Turnover | 28,289,617 | 29,383,647 | 19,947,888 | 7,790,000 | |||
| Other Income Or Grants | |||||||
| Cost Of Sales | 10,539,380 | 11,664,055 | 7,761,893 | 3,115,930 | |||
| Gross Profit | 17,750,237 | 17,719,592 | 12,185,995 | 4,674,070 | |||
| Admin Expenses | 21,786,840 | 19,738,318 | 13,869,278 | 5,699,101 | |||
| Operating Profit | -4,036,603 | -2,018,726 | -1,683,283 | -1,025,031 | |||
| Interest Payable | 71,499 | 3,772 | |||||
| Interest Receivable | |||||||
| Pre-Tax Profit | -4,108,102 | -2,022,498 | -1,683,283 | -1,025,031 | |||
| Tax | 118,744 | -42,511 | -22,296 | -46,605 | |||
| Profit After Tax | -3,989,358 | -2,065,009 | -1,705,579 | -1,071,636 | |||
| Dividends Paid | |||||||
| Retained Profit | -3,989,358 | -2,065,009 | -1,705,579 | -1,071,636 | |||
| Employee Costs | 14,668,925 | 16,863,395 | 10,536,255 | 4,559,353 | |||
| Number Of Employees | 244 | 242 | 155 | 68 | 59 | 37 | 7 |
| EBITDA* | -2,025,664 | -1,041,966 | -1,222,585 | -920,728 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Aug 2019 | Aug 2018 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 298,634 | 324,116 | 296,641 | 152,799 | 208,923 | 215,470 | 14,319 |
| Intangible Assets | 4,803,513 | 4,614,478 | 2,954,918 | 1,145,730 | |||
| Investments & Other | 8 | 8 | |||||
| Debtors (Due After 1 year) | 214,358 | 208,000 | 208,000 | 208,000 | |||
| Total Fixed Assets | 5,102,147 | 4,938,594 | 3,465,917 | 1,506,529 | 416,931 | 423,478 | 14,319 |
| Stock & work in progress | |||||||
| Trade Debtors | 2,865,848 | 3,081,538 | 2,722,153 | 1,319,144 | 822,637 | 439,992 | 107,679 |
| Group Debtors | 13,558 | 12,647 | |||||
| Misc Debtors | 2,694,094 | 3,113,166 | 2,370,289 | 1,875,373 | 757,725 | 909,306 | 49,993 |
| Cash | 3,232,814 | 2,021,128 | 1,332,920 | 5,713,281 | 1,110,603 | 1,507,680 | 826,921 |
| misc current assets | |||||||
| total current assets | 8,792,756 | 8,215,832 | 6,425,362 | 8,907,798 | 2,704,523 | 2,869,625 | 984,593 |
| total assets | 13,894,903 | 13,154,426 | 9,891,279 | 10,414,327 | 3,121,454 | 3,293,103 | 998,912 |
| Bank overdraft | |||||||
| Bank loan | |||||||
| Trade Creditors | 407,403 | 481,023 | 851,010 | 144,723 | 163,139 | 177,363 | 782 |
| Group/Directors Accounts | |||||||
| other short term finances | |||||||
| hp & lease commitments | |||||||
| other current liabilities | 4,435,997 | 2,495,030 | 1,811,038 | 2,123,812 | 1,232,360 | 890,750 | 122,844 |
| total current liabilities | 4,843,400 | 2,976,053 | 2,662,048 | 2,268,535 | 1,395,499 | 1,068,113 | 123,626 |
| loans | 1,500,000 | ||||||
| hp & lease commitments | |||||||
| Accruals and Deferred Income | |||||||
| other liabilities | 63,882 | 90,778 | |||||
| provisions | 1,196,453 | 1,321,453 | 918,211 | 367,822 | 125,000 | 125,000 | |
| total long term liabilities | 2,696,453 | 1,321,453 | 918,211 | 367,822 | 188,882 | 215,778 | |
| total liabilities | 7,539,853 | 4,297,506 | 3,580,259 | 2,636,357 | 1,584,381 | 1,283,891 | 123,626 |
| net assets | 6,355,050 | 8,856,920 | 6,311,020 | 7,777,970 | 1,537,073 | 2,009,212 | 875,286 |
| total shareholders funds | 6,355,050 | 8,856,920 | 6,311,020 | 7,777,970 | 1,537,073 | 2,009,212 | 875,286 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Aug 2019 | Aug 2018 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | -4,036,603 | -2,018,726 | -1,683,283 | -1,025,031 | |||
| Depreciation | 152,492 | 128,740 | 143,112 | 94,265 | 31,088 | 34,039 | 1,122 |
| Amortisation | 1,858,447 | 848,020 | 317,586 | 10,038 | 51,849 | ||
| Tax | 118,744 | -42,511 | -22,296 | -46,605 | |||
| Stock | |||||||
| Debtors | -634,762 | 887,904 | 1,904,283 | 1,600,597 | 1,644,248 | 1,412,273 | 157,672 |
| Creditors | -73,620 | -369,987 | 706,287 | -18,416 | 162,357 | 176,581 | 782 |
| Accruals and Deferred Income | 1,940,967 | 683,992 | -312,774 | 891,452 | 1,109,516 | 767,906 | 122,844 |
| Deferred Taxes & Provisions | -125,000 | 403,242 | 550,389 | 242,822 | 125,000 | 125,000 | |
| Cash flow from operations | 470,189 | -1,255,134 | -2,205,262 | -1,452,072 | |||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | -8 | 8 | 8 | ||||
| cash flow from investments | 8 | ||||||
| Financing Activities | |||||||
| Bank loans | |||||||
| Group/Directors Accounts | |||||||
| Other Short Term Loans | |||||||
| Long term loans | 1,500,000 | ||||||
| Hire Purchase and Lease Commitments | |||||||
| other long term liabilities | -63,882 | 63,882 | 90,778 | ||||
| share issue | |||||||
| interest | -71,499 | -3,772 | |||||
| cash flow from financing | 2,915,989 | 4,607,137 | 238,629 | 7,248,651 | |||
| cash and cash equivalents | |||||||
| cash | 1,211,686 | 688,208 | -4,380,361 | 4,602,678 | 283,682 | 680,759 | 826,921 |
| overdraft | |||||||
| change in cash | 1,211,686 | 688,208 | -4,380,361 | 4,602,678 | 283,682 | 680,759 | 826,921 |
prosapient limited Credit Report and Business Information
Prosapient Limited Competitor Analysis
Perform a competitor analysis for prosapient limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in EC1N area or any other competitors across 12 key performance metrics.
prosapient limited Ownership
PROSAPIENT LIMITED group structure
Prosapient Limited has no subsidiary companies.
Ultimate parent company
PROSAPIENT LIMITED
10704431
prosapient limited directors
Prosapient Limited currently has 8 directors. The longest serving directors include Miss Margaryta Polishchuk (Apr 2017) and Mr Thomas Hoppe (Jun 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Miss Margaryta Polishchuk | United Kingdom | 36 years | Apr 2017 | - | Director |
| Mr Thomas Hoppe | United Kingdom | 66 years | Jun 2019 | - | Director |
| Mr Stephen Holliday | England | 46 years | Aug 2019 | - | Director |
| Mr Stephen Holliday | United Kingdom | 46 years | Aug 2019 | - | Director |
| Mr Robert Toms | United Kingdom | 63 years | Dec 2020 | - | Director |
| Mr Robert Toms | United Kingdom | 63 years | Dec 2020 | - | Director |
| Dr Christopher Potts | 68 years | Nov 2023 | - | Director | |
| Mr Aneil Rakity | United Kingdom | 51 years | Jan 2024 | - | Director |
P&L
December 2023turnover
28.3m
-4%
operating profit
-4m
+100%
gross margin
62.8%
+4.05%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
6.4m
-0.28%
total assets
13.9m
+0.06%
cash
3.2m
+0.6%
net assets
Total assets minus all liabilities
prosapient limited company details
company number
10704431
Type
Private limited with Share Capital
industry
73200 - Market research and public opinion polling
incorporation date
April 2017
age
8
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
MOORE KINGSTON SMITH LLP
address
floor 5 33 holborn, london, EC1N 2HT
Bank
-
Legal Advisor
-
prosapient limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to prosapient limited. Currently there are 1 open charges and 3 have been satisfied in the past.
prosapient limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PROSAPIENT LIMITED. This can take several minutes, an email will notify you when this has completed.
prosapient limited Companies House Filings - See Documents
| date | description | view/download |
|---|
